$ACHN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACHILLION PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACHILLION PHARMACEUTICALS INC. Get notifications about new insider transactions in ACHILLION PHARMACEUTICALS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 30 2009 | ACHN | ACHILLION PHARMACE ... | INVESTOR AB | 10% Owner | Sell | S | 3.15 | 105,500 | 332,325 | 2,175,714 | 2.3 M to 2.2 M (-4.62 %) |
Dec 30 2009 | ACHN | ACHILLION PHARMACE ... | INVESTOR AB | 10% Owner | Sell | S | 3.18 | 29,712 | 94,609 | 1,596,860 | 1.6 M to 1.6 M (-1.83 %) |
Dec 30 2009 | ACHN | ACHILLION PHARMACE ... | INVESTOR AB | 10% Owner | Sell | S | 3.18 | 42,446 | 135,157 | 2,281,214 | 2.3 M to 2.3 M (-1.83 %) |
Dec 29 2009 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 3.53 | 3,600 | 12,695 | 4,673,567 | 4.7 M to 4.7 M (-0.08 %) |
Dec 23 2009 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 3.70 | 264,900 | 981,428 | 4,677,167 | 4.9 M to 4.7 M (-5.36 %) |
Dec 23 2009 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 3.54 | 19,100 | 67,664 | 4,942,067 | 5 M to 4.9 M (-0.38 %) |
Dec 22 2009 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Director | Option Exercise | A | 3.28 | 20,000 | 65,600 | 20,000 | |
Dec 22 2009 | ACHN | ACHILLION PHARMACE ... | GREY MICHAEL G | Director | Option Exercise | A | 3.28 | 20,000 | 65,600 | 20,000 | |
Dec 22 2009 | ACHN | ACHILLION PHARMACE ... | Scheer David | Director | Option Exercise | A | 3.28 | 20,000 | 65,600 | 20,000 | |
Dec 22 2009 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 3.28 | 20,000 | 65,600 | 20,000 | |
Dec 22 2009 | ACHN | ACHILLION PHARMACE ... | WRIGHT DAVID P | Director | Option Exercise | A | 3.28 | 20,000 | 65,600 | 20,000 | |
Dec 22 2009 | ACHN | ACHILLION PHARMACE ... | FRASHIER GARY E | Director | Option Exercise | A | 3.28 | 20,000 | 65,600 | 20,000 | |
Dec 22 2009 | ACHN | ACHILLION PHARMACE ... | Liotta Dennis | Director | Option Exercise | A | 3.28 | 20,000 | 65,600 | 20,000 | |
Dec 22 2009 | ACHN | ACHILLION PHARMACE ... | Simon Nicholas | Director | Option Exercise | A | 3.28 | 20,000 | 65,600 | 20,000 | |
Dec 22 2009 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | VP, Chief Commercia ... | Option Exercise | A | 3.28 | 33,250 | 109,060 | 33,250 | |
Dec 22 2009 | ACHN | ACHILLION PHARMACE ... | Olek Elizabeth A | Vice President and ... | Option Exercise | A | 3.28 | 33,250 | 109,060 | 33,250 | |
Dec 22 2009 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | Vice President and ... | Option Exercise | A | 3.28 | 33,250 | 109,060 | 33,250 | |
Dec 22 2009 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Option Exercise | A | 3.28 | 33,250 | 109,060 | 33,250 | |
Dec 22 2009 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | EVP and CSO | Option Exercise | A | 3.28 | 60,000 | 196,800 | 60,000 | |
Dec 22 2009 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | CEO and President | Option Exercise | A | 3.28 | 142,000 | 465,760 | 142,000 | |
Dec 18 2009 | ACHN | ACHILLION PHARMACE ... | INVESTOR AB | 10% Owner | Sell | S | 3.24 | 87,290 | 283,212 | 1,626,572 | 1.7 M to 1.6 M (-5.09 %) |
Dec 18 2009 | ACHN | ACHILLION PHARMACE ... | INVESTOR AB | 10% Owner | Sell | S | 3.24 | 124,700 | 404,589 | 2,323,660 | 2.4 M to 2.3 M (-5.09 %) |
Dec 18 2009 | ACHN | ACHILLION PHARMACE ... | INVESTOR AB | 10% Owner | Sell | S | 3.35 | 315,000 | 1,056,321 | 1,713,862 | 2 M to 1.7 M (-15.53 %) |
Dec 18 2009 | ACHN | ACHILLION PHARMACE ... | INVESTOR AB | 10% Owner | Sell | S | 3.35 | 450,000 | 1,509,030 | 2,448,360 | 2.9 M to 2.4 M (-15.53 %) |
Dec 18 2009 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 3.50 | 9,900 | 34,650 | 4,961,167 | 5 M to 5 M (-0.20 %) |
Dec 18 2009 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 3.50 | 129,476 | 453,166 | 4,971,067 | 5.1 M to 5 M (-2.54 %) |
Dec 18 2009 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 3.58 | 67,800 | 242,507 | 5,100,543 | 5.2 M to 5.1 M (-1.31 %) |
Dec 18 2009 | ACHN | ACHILLION PHARMACE ... | Moorin Jay | 10% Owner | Sell | S | 3.24 | 70,000 | 227,101 | 2,663,854 | 2.7 M to 2.7 M (-2.56 %) |
Dec 18 2009 | ACHN | ACHILLION PHARMACE ... | Moorin Jay | 10% Owner | Sell | S | 3.52 | 493,452 | 1,737,346 | 2,733,854 | 3.2 M to 2.7 M (-15.29 %) |
Jan 07 2009 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | VP, Chief Commercia ... | Option Exercise | A | 0.82 | 100,000 | 82,000 | 100,000 | |
Dec 22 2008 | ACHN | ACHILLION PHARMACE ... | INVESTOR AB | 10% Owner | Buy | P | 1.00 | 17,500 | 17,500 | 2,028,862 | 2 M to 2 M (+0.87 %) |
Dec 22 2008 | ACHN | ACHILLION PHARMACE ... | INVESTOR AB | 10% Owner | Buy | P | 0.95 | 175,000 | 166,250 | 2,011,362 | 1.8 M to 2 M (+9.53 %) |
Dec 22 2008 | ACHN | ACHILLION PHARMACE ... | INVESTOR AB | 10% Owner | Buy | P | 1.00 | 25,000 | 25,000 | 2,898,360 | 2.9 M to 2.9 M (+0.87 %) |
Dec 22 2008 | ACHN | ACHILLION PHARMACE ... | INVESTOR AB | 10% Owner | Buy | P | 0.95 | 250,000 | 237,500 | 2,873,360 | 2.6 M to 2.9 M (+9.53 %) |
Dec 17 2008 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Director | Option Exercise | A | 1.05 | 20,000 | 21,000 | 20,000 | |
Dec 17 2008 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Option Exercise | A | 1.05 | 43,500 | 45,675 | 43,500 | |
Dec 17 2008 | ACHN | ACHILLION PHARMACE ... | Olek Elizabeth A | Vice President and ... | Option Exercise | A | 1.05 | 55,000 | 57,750 | 55,000 | |
Dec 17 2008 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | CEO and President | Option Exercise | A | 1.05 | 158,000 | 165,900 | 158,000 | |
Dec 17 2008 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | Vice President and ... | Option Exercise | A | 1.05 | 43,500 | 45,675 | 43,500 | |
Dec 17 2008 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | EVP and CSO | Option Exercise | A | 1.05 | 85,000 | 89,250 | 85,000 | |
Dec 17 2008 | ACHN | ACHILLION PHARMACE ... | Liotta Dennis | Director | Option Exercise | A | 1.05 | 25,000 | 26,250 | 25,000 | |
Dec 17 2008 | ACHN | ACHILLION PHARMACE ... | GREY MICHAEL G | Director | Option Exercise | A | 1.05 | 20,000 | 21,000 | 20,000 | |
Dec 17 2008 | ACHN | ACHILLION PHARMACE ... | WRIGHT DAVID P | Director | Option Exercise | A | 1.05 | 20,000 | 21,000 | 20,000 | |
Dec 17 2008 | ACHN | ACHILLION PHARMACE ... | Simon Nicholas | Director | Option Exercise | A | 1.05 | 20,000 | 21,000 | 20,000 | |
Dec 17 2008 | ACHN | ACHILLION PHARMACE ... | Scheer David | Director | Option Exercise | A | 1.05 | 20,000 | 21,000 | 20,000 | |
Dec 17 2008 | ACHN | ACHILLION PHARMACE ... | FRASHIER GARY E | Director | Option Exercise | A | 1.05 | 20,000 | 21,000 | 20,000 | |
Dec 17 2008 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 1.05 | 20,000 | 21,000 | 20,000 | |
Dec 10 2008 | ACHN | ACHILLION PHARMACE ... | INVESTOR AB | 10% Owner | Buy | P | 1.00 | 35,000 | 35,000 | 1,836,362 | 1.8 M to 1.8 M (+1.94 %) |
Dec 10 2008 | ACHN | ACHILLION PHARMACE ... | INVESTOR AB | 10% Owner | Buy | P | 1.01 | 17,500 | 17,675 | 1,801,362 | 1.8 M to 1.8 M (+0.98 %) |
Dec 10 2008 | ACHN | ACHILLION PHARMACE ... | INVESTOR AB | 10% Owner | Buy | P | 1.00 | 50,000 | 50,000 | 2,623,360 | 2.6 M to 2.6 M (+1.94 %) |
Dec 10 2008 | ACHN | ACHILLION PHARMACE ... | INVESTOR AB | 10% Owner | Buy | P | 1.01 | 25,000 | 25,250 | 2,573,360 | 2.5 M to 2.6 M (+0.98 %) |
Dec 08 2008 | ACHN | ACHILLION PHARMACE ... | INVESTOR AB | 10% Owner | Buy | P | 1.00 | 200,000 | 200,800 | 2,548,360 | 2.3 M to 2.5 M (+8.52 %) |
Dec 01 2008 | ACHN | ACHILLION PHARMACE ... | INVESTOR AB | 10% Owner | Buy | P | 1.00 | 24,700 | 24,700 | 2,348,360 | 2.3 M to 2.3 M (+1.06 %) |
Sep 09 2008 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | Vice President and ... | Option Exercise | M | 1.60 | 3,125 | 5,000 | 0 | |
Sep 09 2008 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | Vice President and ... | Buy | M | 1.60 | 3,125 | 5,000 | 21,375 | 18.3 K to 21.4 K (+17.12 %) |
Sep 09 2008 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | P | 2.37 | 1,600 | 3,791 | 5,307,420 | 5.3 M to 5.3 M (+0.03 %) |
Sep 09 2008 | ACHN | ACHILLION PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | P | 2.19 | 3,054 | 6,693 | 5,305,820 | 5.3 M to 5.3 M (+0.06 %) |
Sep 02 2008 | ACHN | ACHILLION PHARMACE ... | Olek Elizabeth A | Vice President and ... | Buy | P | 2.46 | 1,500 | 3,690 | 2,000 | 500 to 2 K (+300.00 %) |
Sep 02 2008 | ACHN | ACHILLION PHARMACE ... | Olek Elizabeth A | Vice President and ... | Buy | P | 2.29 | 500 | 1,145 | 500 | 0 to 500 |
Aug 20 2008 | ACHN | ACHILLION PHARMACE ... | Simon Nicholas | Director | Option Exercise | A | 2.59 | 25,000 | 64,750 | 25,000 | |
Aug 20 2008 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 2.66 | 10,000 | 26,600 | 10,000 | |
Aug 20 2008 | ACHN | ACHILLION PHARMACE ... | FRASHIER GARY E | Director | Option Exercise | A | 2.66 | 10,000 | 26,600 | 10,000 | |
Aug 20 2008 | ACHN | ACHILLION PHARMACE ... | WRIGHT DAVID P | Director | Option Exercise | A | 2.66 | 10,000 | 26,600 | 10,000 | |
Aug 20 2008 | ACHN | ACHILLION PHARMACE ... | GREY MICHAEL G | Director | Option Exercise | A | 2.66 | 10,000 | 26,600 | 10,000 | |
Aug 20 2008 | ACHN | ACHILLION PHARMACE ... | Scheer David | Director | Option Exercise | A | 2.66 | 10,000 | 26,600 | 10,000 | |
Apr 02 2008 | ACHN | ACHILLION PHARMACE ... | FRASHIER GARY E | Director | Option Exercise | A | 4.43 | 15,000 | 66,450 | 15,000 | |
Dec 18 2007 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Director | Option Exercise | A | 4.82 | 15,000 | 72,300 | 15,000 | |
Dec 18 2007 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | EVP and CSO | Option Exercise | A | 4.82 | 60,000 | 289,200 | 60,000 | |
Dec 18 2007 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Option Exercise | A | 4.82 | 45,000 | 216,900 | 45,000 | |
Dec 18 2007 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | CEO and President | Option Exercise | A | 4.82 | 150,000 | 723,000 | 150,000 | |
Dec 18 2007 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | Vice President and ... | Option Exercise | A | 4.82 | 45,000 | 216,900 | 45,000 | |
Dec 18 2007 | ACHN | ACHILLION PHARMACE ... | GREY MICHAEL G | Director | Option Exercise | A | 4.82 | 15,000 | 72,300 | 15,000 | |
Dec 18 2007 | ACHN | ACHILLION PHARMACE ... | Scheer David | Director | Option Exercise | A | 4.82 | 15,000 | 72,300 | 15,000 | |
Dec 18 2007 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 4.82 | 15,000 | 72,300 | 15,000 | |
Dec 18 2007 | ACHN | ACHILLION PHARMACE ... | WRIGHT DAVID P | Director | Option Exercise | A | 4.82 | 15,000 | 72,300 | 15,000 | |
Dec 18 2007 | ACHN | ACHILLION PHARMACE ... | GARVEY JAMES M | Director | Option Exercise | A | 4.82 | 15,000 | 72,300 | 15,000 | |
Dec 18 2007 | ACHN | ACHILLION PHARMACE ... | FORMELA JEAN FRANCOIS | Director | Option Exercise | A | 4.82 | 15,000 | 72,300 | 15,000 | |
Dec 07 2007 | ACHN | ACHILLION PHARMACE ... | Olek Elizabeth A | Vice President and ... | Option Exercise | A | 4.91 | 60,000 | 294,600 | 60,000 | |
Aug 22 2007 | ACHN | ACHILLION PHARMACE ... | WRIGHT DAVID P | Director | Option Exercise | A | 7.44 | 15,000 | 111,600 | 15,000 | |
Jun 08 2007 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | EVP and CSO | Option Exercise | A | 5.41 | 47,900 | 259,139 | 47,900 | |
May 01 2007 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 5.76 | 15,000 | 86,400 | 15,000 | |
Apr 27 2007 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Option Exercise | M | 1.60 | 1,025 | 1,640 | 0 | |
Apr 27 2007 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Option Exercise | M | 1.60 | 2,100 | 3,360 | 0 | |
Apr 27 2007 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Sell | S | 5.77 | 100 | 577 | 3,125 | 3.2 K to 3.1 K (-3.10 %) |
Apr 27 2007 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Sell | S | 5.76 | 200 | 1,152 | 3,225 | 3.4 K to 3.2 K (-5.84 %) |
Apr 27 2007 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Sell | S | 5.74 | 225 | 1,292 | 3,425 | 3.7 K to 3.4 K (-6.16 %) |
Apr 27 2007 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Sell | S | 5.72 | 300 | 1,716 | 3,650 | 4 K to 3.7 K (-7.59 %) |
Apr 27 2007 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Sell | S | 5.67 | 200 | 1,134 | 3,950 | 4.2 K to 4 K (-4.82 %) |
Apr 27 2007 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Buy | M | 1.60 | 1,025 | 1,640 | 4,150 | 3.1 K to 4.2 K (+32.80 %) |
Apr 27 2007 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Sell | S | 5.92 | 100 | 592 | 3,125 | 3.2 K to 3.1 K (-3.10 %) |
Apr 27 2007 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Sell | S | 5.84 | 100 | 584 | 3,225 | 3.3 K to 3.2 K (-3.01 %) |
Apr 27 2007 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Sell | S | 5.82 | 1,700 | 9,894 | 3,325 | 5 K to 3.3 K (-33.83 %) |
Apr 27 2007 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Sell | S | 5.81 | 200 | 1,162 | 5,025 | 5.2 K to 5 K (-3.83 %) |
Apr 27 2007 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Buy | M | 1.60 | 2,100 | 3,360 | 5,225 | 3.1 K to 5.2 K (+67.20 %) |
Jan 11 2007 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Option Exercise | M | 1.60 | 3,125 | 5,000 | 15,000 | |
Jan 11 2007 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Buy | M | 1.60 | 3,125 | 5,000 | 3,125 | 0 to 3.1 K |
Jan 11 2007 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | Vice President and ... | Option Exercise | M | 1.60 | 1,250 | 2,000 | 0 | |
Jan 11 2007 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | Vice President and ... | Buy | M | 1.60 | 1,250 | 2,000 | 1,250 | 0 to 1.3 K |
Dec 26 2006 | ACHN | ACHILLION PHARMACE ... | Pottage John C Jr | SVP and Chief Medic ... | Option Exercise | A | 14.75 | 40,000 | 590,000 | 40,000 | |
Dec 26 2006 | ACHN | ACHILLION PHARMACE ... | Scheer David | Director | Option Exercise | A | 14.75 | 15,000 | 221,250 | 15,000 | |
Dec 26 2006 | ACHN | ACHILLION PHARMACE ... | GREY MICHAEL G | Director | Option Exercise | A | 14.75 | 15,000 | 221,250 | 15,000 | |
Dec 26 2006 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | SVP and Chief Compl ... | Option Exercise | A | 14.75 | 22,000 | 324,500 | 22,000 | |
Dec 26 2006 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | Vice President and ... | Option Exercise | A | 14.75 | 49,000 | 722,750 | 49,000 | |
Dec 26 2006 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | SVP and CSO | Option Exercise | A | 14.75 | 46,000 | 678,500 | 46,000 | |
Dec 26 2006 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | CEO and President | Option Exercise | A | 14.75 | 160,000 | 2,360,000 | 160,000 | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Director | Option Exercise | C | 0.00 | 2,133 | 0 | 0 | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Director | Option Exercise | C | 0.00 | 1,653 | 0 | 0 | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Director | Option Exercise | C | 0.00 | 4,820 | 0 | 0 | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Director | Buy | C | 0.00 | 1,115 | 0 | 1,115 | 0 to 1.1 K |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT PARTNERS LIMITED PARTNE ... | Option Exercise | C | 0.00 | 17,496 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT PARTNERS LIMITED PARTNE ... | Option Exercise | C | 0.00 | 13,558 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT PARTNERS LIMITED PARTNE ... | Option Exercise | C | 0.00 | 39,530 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT PARTNERS LIMITED PARTNE ... | Buy | C | 0.00 | 9,152 | 0 | 9,152 | 0 to 9.2 K | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT PARTNERS HLS II LIMITED ... | Option Exercise | C | 0.00 | 42,675 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT PARTNERS HLS II LIMITED ... | Option Exercise | C | 0.00 | 33,069 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT PARTNERS HLS II LIMITED ... | Option Exercise | C | 0.00 | 96,412 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT PARTNERS HLS II LIMITED ... | Buy | C | 0.00 | 22,326 | 0 | 22,326 | 0 to 22.3 K | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT INTERNATIONAL LIMITED P ... | Option Exercise | C | 0.00 | 2,073,582 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT INTERNATIONAL LIMITED P ... | Option Exercise | C | 0.00 | 1,606,805 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT INTERNATIONAL LIMITED P ... | Option Exercise | C | 0.00 | 4,684,695 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT INTERNATIONAL LIMITED P ... | Buy | C | 0.00 | 1,084,954 | 0 | 1,084,954 | 0 to 1.1 M | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT INTERNATIONAL CORP/MA | Option Exercise | C | 0.00 | 2,133,753 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT INTERNATIONAL CORP/MA | Option Exercise | C | 0.00 | 1,653,432 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT INTERNATIONAL CORP/MA | Option Exercise | C | 0.00 | 4,820,637 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT INTERNATIONAL CORP/MA | Buy | C | 0.00 | 1,116,432 | 0 | 1,116,432 | 0 to 1.1 M | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT HEALTHCARE & LIFE SCIE ... | Option Exercise | C | 0.00 | 1,923,793 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT HEALTHCARE & LIFE SCIE ... | Option Exercise | C | 0.00 | 1,490,734 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT HEALTHCARE & LIFE SCIE ... | Option Exercise | C | 0.00 | 4,346,286 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT HEALTHCARE & LIFE SCIE ... | Buy | C | 0.00 | 1,006,582 | 0 | 1,006,582 | 0 to 1 M | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT HEALTHCARE & LIFE SCIE ... | Option Exercise | C | 0.00 | 149,789 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT HEALTHCARE & LIFE SCIE ... | Option Exercise | C | 0.00 | 116,071 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT HEALTHCARE & LIFE SCIE ... | Option Exercise | C | 0.00 | 338,409 | 0 | 0 | ||
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ADVENT HEALTHCARE & LIFE SCIE ... | Buy | C | 0.00 | 78,372 | 0 | 78,372 | 0 to 78.4 K | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | SCHRODER VENTURE MANAGERS LTD | 10% Owner | Option Exercise | C | 0.00 | 3,656,461 | 0 | 0 | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | SCHRODER VENTURE MANAGERS LTD | 10% Owner | Option Exercise | C | 0.00 | 3,306,866 | 0 | 0 | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | SCHRODER VENTURE MANAGERS LTD | 10% Owner | Option Exercise | C | 0.00 | 6,071,204 | 0 | 0 | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | SCHRODER VENTURE MANAGERS LTD | 10% Owner | Buy | C | 0.00 | 1,710,231 | 0 | 1,710,231 | 0 to 1.7 M |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | GARVEY JAMES M | Director | Option Exercise | C | 0.00 | 3,656,461 | 0 | 0 | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | GARVEY JAMES M | Director | Option Exercise | C | 0.00 | 3,306,866 | 0 | 0 | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | GARVEY JAMES M | Director | Option Exercise | C | 0.00 | 6,071,204 | 0 | 0 | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | GARVEY JAMES M | Director | Buy | C | 0.00 | 1,710,231 | 0 | 1,710,231 | 0 to 1.7 M |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | FORMELA JEAN FRANCOIS | Director | Option Exercise | C | 0.00 | 4,142,227 | 0 | 0 | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | FORMELA JEAN FRANCOIS | Director | Option Exercise | C | 0.00 | 4,629,610 | 0 | 0 | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | FORMELA JEAN FRANCOIS | Director | Option Exercise | C | 0.00 | 6,071,207 | 0 | 0 | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | FORMELA JEAN FRANCOIS | Director | Buy | C | 0.00 | 1,968,670 | 0 | 1,968,670 | 0 to 2 M |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ATLAS VENTURE FUND V LP | 10% Owner | Option Exercise | C | 0.00 | 4,142,227 | 0 | 0 | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ATLAS VENTURE FUND V LP | 10% Owner | Option Exercise | C | 0.00 | 4,629,610 | 0 | 0 | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ATLAS VENTURE FUND V LP | 10% Owner | Option Exercise | C | 0.00 | 6,071,207 | 0 | 0 | |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | ATLAS VENTURE FUND V LP | 10% Owner | Buy | C | 0.00 | 1,968,670 | 0 | 1,968,670 | 0 to 2 M |
Nov 02 2006 | ACHN | ACHILLION PHARMACE ... | WHITE CHRISTOPHER A | Director | Option Exercise | C | 0.00 | 1,250,476 | 0 | 0 |